Enveric Biosciences
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ENVB and other ETFs, options, and stocks.About ENVB
Enveric Biosciences, Inc. is a biotechnology company which engages in the development of neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company was founded on February 28, 1994 and is headquartered in Cambridge, MA.
CEOJoseph Tucker
CEOJoseph Tucker
Employees5
Employees5
HeadquartersCambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded1994
Founded1994
Employees5
Employees5
ENVB Key Statistics
Market cap3.14M
Market cap3.14M
Price-Earnings ratio-0.05
Price-Earnings ratio-0.05
Dividend yield—
Dividend yield—
Average volume225.42K
Average volume225.42K
High today$6.38
High today$6.38
Low today$5.75
Low today$5.75
Open price$5.91
Open price$5.91
Volume44.39K
Volume44.39K
52 Week high$96.30
52 Week high$96.30
52 Week low$5.52
52 Week low$5.52
Stock Snapshot
The current Enveric Biosciences(ENVB) stock price is $6.11, with a market capitalization of 3.14M. The stock trades at a price-to-earnings (P/E) ratio of -0.05.
On 2025-11-07, Enveric Biosciences(ENVB) stock traded between a low of $5.75 and a high of $6.38. Shares are currently priced at $6.11, which is +6.3% above the low and -4.2% below the high.
Enveric Biosciences(ENVB) shares are trading with a volume of 44.39K, against a daily average of 225.42K.
In the last year, Enveric Biosciences(ENVB) shares hit a 52-week high of $96.30 and a 52-week low of $5.52.
In the last year, Enveric Biosciences(ENVB) shares hit a 52-week high of $96.30 and a 52-week low of $5.52.
People also own
Based on the portfolios of people who own ENVB. This list is generated using Robinhood data, and it’s not a recommendation.